China’s vaccine makers get stock market jolt as rivalry, price cuts undermine earnings outlook

Since a 55 per cent breakout in early last year, China’s top vaccine producers have slumped from Shanghai to Shenzhen and Hong Kong, making investors US$12.7 billion poorer on paper this year.

Read the original article at South China Morning Post